Real world switching therapies analysis in a retro-prospective cohort of patients with multiple sclerosis

被引：0
|
作者：
Mallucci, G. [1 ]
Zito, A. [1 ]
Bergamaschi, R. [1 ]
机构：
[1] IRCCS Mondino, Pavia, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P846
引用
收藏
页码：696 / 697
页数：2
相关论文
共 50 条
  • [21] Switching disease modifying therapies in multiple sclerosis patients: a study on 110 patients
    Morra, VB
    Coppola, G
    Vacca, G
    Longobardi, M
    Ascione, S
    Schiavone, V
    Pagano, A
    Bonavita, V
    Orefice, G
    JOURNAL OF NEUROLOGY, 2004, 251 : 88 - 88
  • [22] Switching From Natalizumab To Immune Reconstitution Therapies In Patients With Multiple Sclerosis
    Matos, Sara
    Cunha, Carolina
    Bernardes, Catarina
    Cardoso, Joao
    Campelo, Isabel
    Feio, Jose
    Batista, Sonia
    Nunes, Carla
    Macario, Maria do Carmo
    Sousa, Livia Maria
    Correia, Ines
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 931 - 931
  • [23] Eribulin is safe and efficient in metastatic breast cancer in elderly patients. Results from the REPROLINE multicentric retro-prospective cohort
    Martin-Babau, J.
    Robert, M.
    Seegers, V.
    Paillard, M-J.
    Pivot, X.
    Gourmelon, C.
    Uwer, L.
    Korenbaum, C.
    Petit, T.
    Thery, J-C.
    Som, M.
    Lefeuvre-Plesse, C.
    Perret, C.
    Simon, H.
    Hardy-Bessard, A-C.
    Desclos, H.
    Bourgeois, H.
    Campone, M.
    Tredan, O.
    Patsouris, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [24] Circulating miRNA signature of esophageal squamous cell carcinoma diagnosis:retro-prospective multinational cohort study
    Miyoshi, Jinsei
    Toden, Shusuke
    Izumi, Daisuke
    Kanda, Mitsuro
    Sato, Yasushi
    Muguruma, Naoki
    Baba, Hideo
    Kodera, Yasuhiro
    Goel, Ajay
    Takayama, Tetsuji
    CANCER SCIENCE, 2021, 112 : 527 - 527
  • [25] Real-World Effectiveness of Disease-Modifying Therapies in Korean Patients with Relapsing Multiple Sclerosis
    Kim, Su-Hyun
    Park, Min Su
    Kim, Woojun
    Huh, So-Young
    Shin, Hyun-June
    Hyun, Jae-Won
    Kim, Ho Jin
    JOURNAL OF CLINICAL NEUROLOGY, 2019, 15 (01): : 20 - 26
  • [26] Real-World Treatment Persistence Among Multiple Sclerosis Patients on Injectable Disease Modifying Therapies
    Ko, John
    Nicholas, Jacqueline
    Navaratnam, Prakash
    Friedman, Howard
    Ernst, Frank
    Herrera, Vivian
    NEUROLOGY, 2017, 88
  • [27] Predicting relapse episodes in patients with multiple sclerosis treated with disease modifying therapies in a large representative real-world cohort in the United States
    Behling, Michael
    Bryant, Allison
    Brecht, Tom
    Cerf, Shannon
    Gliklich, Richard
    Su, Zhaohui
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 130 - 130
  • [28] Adherence to disease-modifying therapies among patients with multiple sclerosis in Bulgaria - A real world study
    Seitaridou, Yoana
    Chamova, Teodora
    Kamusheva, Maria
    PHARMACIA, 2024, 71 : 1 - 7
  • [29] A five-year observational prospective mono centre study of efficacy of alemtuzumab in a real-world cohort of patients with multiple sclerosis
    Sandgren, Sofia
    Novakova, Lenka
    Nordin, Anna
    Axelsson, Markus
    Malmestrom, Clas
    Zetterberg, Henrik
    Lycke, Jan
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 632 - 633
  • [30] Real-World Experience with Diroximel Fumarate in Patients with Multiple Sclerosis: A Prospective Multicenter Study
    Aguirre, Clara
    Alonso-Torres, Ana
    Aguera, Eduardo
    Garcia-Dominguez, Jose Manuel
    Montero-Escribano, Paloma
    Gonzalez-Quintanilla, Vicente
    Costa-Frossard, Lucienne
    Oreja-Guevara, Celia
    Reyes-Garrido, Virginia
    Caminero-Rodriguez, Ana Belen
    Riancho, Javier
    Sanchez, Octavio
    Forero, Lucia
    Perez-Parra, Fernando
    Ares-Luque, Adrian
    Tellez, Nieves
    Arzalluz-Luque, Joaquin
    Iglesias, Federico
    Casado-Ruiz, Virginia
    Castellano-Vicente, Alberto Jose
    Borrega, Laura
    Galan, Victoria
    de Antonio, Luis A. Rodriguez
    Romero, Carlos
    Garcia-Rodriguez, Raquel
    Cano-Orgaz, Antonio Tomas
    Sanchez-Menoyo, Jose Luis
    Perez-Ruiz, Domingo
    Gutierrez-Martin, Fuencisla
    Hernandez-Echevarria, Luis
    Meca-Lallana, Virginia
    CLINICAL DRUG INVESTIGATION, 2024, 44 (11) : 829 - 838
12345